119 Participants Needed

REGENETEN™ Bioinductive Implant System in Full-thickness Tears

(REGENETEN Trial)

Recruiting at 29 trial locations
IA
RW
LE
SN
Overseen BySalomé Nel
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Smith & Nephew, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial is testing a shoulder tendon repair surgery with an extra treatment called REGENETEN. It targets patients with large or massive shoulder tears. REGENETEN helps by providing a structure for new tissue to grow, aiding the healing process. REGENETEN is a bioinductive type-1 collagen implant used to repair partial-thickness rotator cuff tears without formal tendon-bone reattachment.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you have used oral or injected steroids in the last 4 weeks, you may not be eligible to participate.

What data supports the effectiveness of the treatment Arthroscopic rotator cuff repair with the REGENETEN™ Bioinductive Implant System?

Research shows that using the REGENETEN bio-inductive collagen implant in rotator cuff repair can increase tendon thickness and improve healing rates, reducing the chances of the tear happening again. Studies also indicate that this implant can enhance clinical outcomes for patients with full-thickness rotator cuff tears.12345

Is the REGENETEN Bioinductive Implant safe for humans?

The REGENETEN Bioinductive Implant, used in rotator cuff repair, has been shown to be safe in humans, with studies indicating it can be used effectively to promote healing in rotator cuff tears.12346

How is the REGENETEN Bioinductive Implant treatment different from other treatments for rotator cuff repair?

The REGENETEN Bioinductive Implant is unique because it uses a bio-inductive collagen implant to promote new tissue growth and increase tendon thickness, which can help improve healing in rotator cuff repairs. Unlike other treatments that may provide immediate structural support, this implant focuses on enhancing the body's natural healing process over time.23578

Research Team

CP

Chris Peach, MBBS MD FRCS (Tr&Orth)

Principal Investigator

Manchester University NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

You need to have surgery to repair a rotator cuff tear using arthroscopy.
Subject is > 40 years of age (no upper limit);
Subject provides written informed consent for study participation using an Independent Ethical Committee (IEC) / Institutional Review Board (IRB) approved consent form;
See 2 more

Exclusion Criteria

You have a current or previous shoulder infection on the same side as the study treatment.
You are allergic to substances that come from cows.
You have a tear in your shoulder muscle that cannot be fully repaired.
See 17 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo Arthroscopic rotator cuff repair (ARCR) with or without REGENETEN™ Bioinductive Implant

Intra-operative time

Initial Follow-up

Participants are monitored post-surgery at 2 weeks and 6 weeks for initial recovery and assessment

6 weeks
2 visits (in-person)

Extended Follow-up

Participants are monitored for safety and effectiveness at 3, 6, 12, and 24 months post-surgery

24 months
4 visits (in-person)

Treatment Details

Interventions

  • Arthroscopic rotator cuff repair
  • Arthroscopic rotator cuff repair for revision surgery
  • REGENETEN™ Bioinductive Implant System
Participant Groups
3Treatment groups
Experimental Treatment
Placebo Group
Group I: ARCR revision groupExperimental Treatment1 Intervention
ARCR revision group allows treatment of subjects having recurrent tears, ARCR supplemented with REGENETEN
Group II: ARCR augmented with REGENETEN™ Bioinductive ImplantExperimental Treatment1 Intervention
During the ARCR procedure, the REGENETEN™ Bioinductive Implant is covering the tendon and attached to the bone and the tendon with small anchors.
Group III: ARCR alonePlacebo Group1 Intervention
The rotator cuff is repaired during arthroscopic standard procedure. No product is added for healing

Find a Clinic Near You

Who Is Running the Clinical Trial?

Smith & Nephew, Inc.

Lead Sponsor

Trials
176
Recruited
23,500+
Dr. Maria Berkman profile image

Dr. Maria Berkman

Smith & Nephew, Inc.

Chief Medical Officer since 2023

MD from Harvard Medical School

Dr. Deepak Nath profile image

Dr. Deepak Nath

Smith & Nephew, Inc.

Chief Executive Officer since 2022

PhD in Theoretical Mechanics, University of California, Berkeley

Findings from Research

In a study of 22 patients with massive rotator cuff tears, only 41% achieved substantial clinical benefit from biologically enhanced patch augmentation repair, indicating that while some patients improved, many did not experience significant recovery.
The procedure showed a significant increase in shoulder function as measured by the Simple Shoulder Test, but pain score improvements were not statistically significant, suggesting that while the technique may enhance function, it may not effectively reduce pain.
Clinical Outcomes Following Biologically Enhanced Patch Augmentation Repair as a Salvage Procedure for Revision Massive Rotator Cuff Tears.Muench, LN., Kia, C., Jerliu, A., et al.[2020]
The recurrence of rotator cuff tears after arthroscopic repair is often due to failure of tendon healing, which can be linked to poor tissue quality.
The use of a resorbable bio-inductive collagen implant (REGENETEN) has been shown to enhance tendon thickness during rotator cuff repair, potentially improving healing outcomes.
Tips and Tricks for Augmenting Rotator Cuff Repair With a Bio-inductive Collagen Implant.Pupa, L., Sheth, M., Goldenberg, N., et al.[2022]
In a study of 115 patients with full-thickness rotator cuff tears, the use of a bioinductive bovine collagen implant during repair resulted in a low retear rate of 16.5% at one year, which is favorable compared to existing literature.
Patients showed significant improvement in shoulder function, with 91.7% meeting the minimally clinically important difference in the American Shoulder and Elbow Surgeons (ASES) score at one year, indicating that the collagen implant may enhance recovery outcomes after rotator cuff repair.
Retear rates and clinical outcomes at 1 year after repair of full-thickness rotator cuff tears augmented with a bioinductive collagen implant: a prospective multicenter study.Bushnell, BD., Connor, PM., Harris, HW., et al.[2022]

References

Clinical Outcomes Following Biologically Enhanced Patch Augmentation Repair as a Salvage Procedure for Revision Massive Rotator Cuff Tears. [2020]
Tips and Tricks for Augmenting Rotator Cuff Repair With a Bio-inductive Collagen Implant. [2022]
Retear rates and clinical outcomes at 1 year after repair of full-thickness rotator cuff tears augmented with a bioinductive collagen implant: a prospective multicenter study. [2022]
Full-Thickness Rotator Cuff Tears Can Be Safely Treated With a Resorbable Bioinductive Bovine Collagen Implant: One-Year Results of a Prospective, Multicenter Registry. [2022]
Arthroscopic Rotator Cuff Repair Technique Using a Bio-Composite Scaffold for Tissue Augmentation. [2022]
Patch Augmentation in Rotator Cuff Repair. [2020]
Arthroscopic Revision of Medial Rotator Cuff Failure Augmented With a Bioabsorbable Patch. [2020]
Arthroscopic revision of failed rotator cuff repairs: technique and results. [2022]